Patents by Inventor Benjamin Dallas Flies

Benjamin Dallas Flies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11390675
    Abstract: Siglec-15 binding molecules are provides. The molecules are typically an antibody or antigen binding fragment thereof that immunospecifically binds to Siglec-15. Siglec-15 ligand-binding molecules are also provided. The molecules are typically Siglec-15 polypeptide or fusion protein. Methods of using the molecules to reduce Siglec-15 mediated immunosuppression in a subject in need thereof are also provided.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: July 19, 2022
    Assignee: NEXTCURE, INC.
    Inventors: Linda Liu, Benjamin Dallas Flies, Solomon Langermann
  • Publication number: 20190202912
    Abstract: Siglec-15 binding molecules are provides. The molecules are typically an antibody or antigen binding fragment thereof that immunospecifically binds to Siglec-15. Siglec-15 ligand-binding molecules are also provided. The molecules are typically Siglec-15 polypeptide or fusion protein. Methods of using the molecules to reduce Siglec-15 mediated immunosuppression in a subject in need thereof are also provided.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 4, 2019
    Inventors: Linda Liu, Benjamin Dallas Flies, Solomon Langermann